These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15763194)

  • 1. Uveal melanoma: genetic aspects.
    Singh AD; Damato B; Howard P; Harbour JW
    Ophthalmol Clin North Am; 2005 Mar; 18(1):85-97, viii. PubMed ID: 15763194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects.
    Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L
    Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
    Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
    Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
    White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
    Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of CpG island promoters in uveal melanoma.
    Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
    Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics in the management of uveal melanoma: are we there yet?
    Robertson DM
    Arch Ophthalmol; 2008 Mar; 126(3):409-10. PubMed ID: 18332323
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
    Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
    Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
    Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
    Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylation in uveal melanoma.
    van der Velden PA; Maat W
    Br J Ophthalmol; 2009 Jan; 93(1):132. PubMed ID: 18650211
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosomal aberrations defining uveal melanoma of poor prognosis.
    Prescher G; Bornfeld N; Horsthemke B; Becher R
    Lancet; 1992 Mar; 339(8794):691-2. PubMed ID: 1347396
    [No Abstract]   [Full Text] [Related]  

  • 16. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
    Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
    Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of RASSF1a in uveal melanoma.
    Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status.
    Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA
    Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.